Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Large-scale population imaging reveals robust sparse coding in Drosophila mushroom body

A research team at Cold Spring Harbor Laboratory (CSHL) led by Assistant Professor Glenn Turner has published results of experiments that show large populations of neurons in the brains of living fruit flies responding simultaneously to a variety of odors.

19 Aug 2011

Flu immunization targets fall short for health workers and pregnant women

According to a new survey despite recent improvements in influenza vaccination rates among U.S. health care personnel, their rates for the 2010-2011 flu season still fell short of national health objectives.

18 Aug 2011

Multi-country study of severe pneumonia in hospitalized children

The Johns Hopkins Bloomberg School of Public Health announced on Tuesday the launch of "a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study … a large multi-country case-control study of severe pneumonia in hospitalized children under five years of age … being conducted in Bangladesh, The Gambia, Kenya, Mali, South Africa, Thailand, and Zambia," according to a JHSPH press release.

18 Aug 2011

Vitamin C shows promise against Alzheimer's disease

Researchers at Lund University have discovered a new function for vitamin C. Treatment with vitamin C can dissolve the toxic protein aggregates that build up in the brain in Alzheimer's disease.

18 Aug 2011

World must invest equally in bird flu prevention and response

The "reports during the past two weeks of two recent infections and another death" from H5N1 (avian) influenza "raised little concern except among public health officials," Robert Gatter, co-director of the Center for Health Law Studies and professor of law at Saint Louis University, writes in an Atlanta Journal-Constitution opinion piece, adding that "the fact that bird flu in developing nations receives little public attention reveals that the world has become complacent about this threat."

18 Aug 2011

Skin infection admissions are now the seventh-most-common reason for hospitalizations

The number of children hospitalized for skin and soft-tissue infections, most due to community-acquired Methicillin-resistant Staphylococcus aureus (MRSA), has more than doubled since 2000, a study by researchers at UC Davis and elsewhere has found.

18 Aug 2011

PERCH study to look at current and likely future causes of childhood pneumonia

Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.

17 Aug 2011

Emotions hinder disease eradication

In a New York Times essay, journalist Donald McNeil writes, "To a doctor, all epidemics are objectively different … But to the mortals they mow down, all epidemics are emotionally alike — an onslaught of fear, awe, repulsion, stigma, denial, rage and blame — and doctors would be foolish to forget that."

17 Aug 2011

Volunteen Program at St. Jude Children's Research Hospital

Each summer, a select group of teenagers spend five weeks of their summer vacation to help children with cancer and other catastrophic diseases through the Volunteen Program at St. Jude Children's Research Hospital. The annual program allows teens to explore career paths and develop leadership and team-building skills while helping patients.

17 Aug 2011

Study finds broadest immune response from LAIV nasal spray vaccines for children

Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, inhaled through a nasal spray or provided through one dose of each in any order, according to researchers funded by the National Institutes of Health.

17 Aug 2011

Scientists define relationship between two prostate tumor suppressor genes

Of the 250,000 American men who will be diagnosed with prostate cancer this year, very few of them-about 1 percent-will develop lethal, metastatic disease. Finding a way to distinguish between this small cohort and the majority of patients who will develop an indolent, non-lethal form of prostate cancer is a key goal in prostate cancer research.

16 Aug 2011

Zinc lozenges might reduce duration of common cold episodes by 40%

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, says Dr. Harri Hemila from the University of Helsinki.

16 Aug 2011

Tel Aviv University scientists work to determine how H1N1 becomes pandemic

The last century has seen two major pandemics caused by the H1N1 virus - the Spanish Flu in 1918 and 2009's Swine Flu scare, which had thousands travelling with surgical masks and clamoring for vaccination. But scientists did not know what distinguished the Swine Flu from ordinary influenza in pigs or seasonal outbreaks in humans, giving it the power to travel extensively and infect large populations.

16 Aug 2011

AVI BioPharma, MDA to initiate exon-51 Phase 2 trial in Duchenne muscular dystrophy

More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy.

16 Aug 2011

New ‘cure-all’ antiviral method discovered

In a new development that could transform how viral infections are treated, a team of researchers at MIT’s Lincoln Laboratory has designed a drug that can identify cells that have been infected by any type of virus, then kill those cells to terminate the infection.

15 Aug 2011

Kineta's next generation antiviral program receives $2.8 million NIH SBIR grant

Kineta, Inc. announced today its next generation antiviral program has received a 2.8 million dollar grant from the National Institute of Allergy and Infectious Disease, a part of the National Institutes of Health (NIH). Awarded under the Small Business Innovation Research (SBIR) program, the prestigious phase two grant will provide on-going support for Kineta's work on a new class of antiviral drugs targeting an array of global, deadly viruses.

12 Aug 2011

National Center for Toxicological Research celebrates 40th birthday

A federal research center established by President Nixon in the Cold War era is celebrating its 40th birthday and its reputation as one of the world's premier science centers.

12 Aug 2011

Faith influences health behaviors of American Muslim patients

The perceived role of God in illness and recovery is a primary influence upon the health care beliefs and behaviors of American Muslims, a first-of-its-kind study has discovered. Outreach and education efforts by the health care community can help address Muslim concerns and improve health care quality in this rapidly growing population, the report recommends.

12 Aug 2011

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2011.

12 Aug 2011